Investors

Investors arrow
Print E-mail

Peregrine Pharmaceuticals, Inc.

Corporate and Media Relations

Investors

14282 Franklin Avenue,
Tustin, CA 92780
Phone: 714-508-6000
Fax: 714-838-5817

Linda Donaldson
14282 Franklin Avenue
Tustin, CA 92780

Tel: 714-508-6067
Fax: 714-838-5817
pr@peregrineinc.com

GendeLLindheim BioCom Partners, LLC
Barbara Lindheim
48 Wall Street, Suite 1100
New York, NY 10005 

Tel: 212-918-4949
Tel: 800-987-8256


Featured Event  
Jul 14, 2008 at 11:30 AM ET
Fiscal Year 2008 Financial Results Conference Call


Recent Press Releases  
Jul 23, 2008
Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
Jul 14, 2008
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008

View all releases »

Stock Information  
NASD:PPHM
$0.36   + 0.02
Aug 8, 2008
2:17 PM ET
Quotes delayed at least 20 minutes. Information provided by TurboFeed.
Shareholder Tools  
 
 
© 2003/2008 Peregrine Pharmaceuticals Inc., All Rights Reserved   Disclaimer | Safe Harbor